(6452.TW) 康友制药控股有限公司

Pharmally International Holding Company Limited (hereinafter ‘Pharmally’) was established in 2013 with the registered capital of TWD1 billion. The current share capital of Pharmally is TWD0.68 billion and the number of employees is about 1,200. Luan Worldbest Pharmaceutical Company Limited (hereinafter ‘Luan Worldbest’), the wholly-own subsidiary of Pharmally, is the production base of Pharmally, with an area of 300 acres. Annual production capacity: • 250 million glass bottles per year,• 195 million plastic bottles per year,• 85 million soft bags of infusion (non-PVC coextrusion film bags) per year,• 300 tons of Nicotianamine raw materials per year, and• 160 tons of Levofloxacin lactate raw materials per year.At present, the company is actively involved in the production of animal vaccines, cooperating with Harbin Weike Biotechnology Development Company, which owns the most advanced bird flu vaccine technology in the world, to set up a poultry vaccine manufacturing enterprise in Indonesia, so as to expand its growth. By expanding overseas, the company will diversify its pharmaceutical products, from the production of human pharmaceuticals to the production of animal vaccines. It will also speed up the globalization strategy of Pharmally, extending the market from China to Indonesia and even ASEAN.With the business philosophy of caring for life, diligence and dedication, Pharmally set up a group of top professional team, through its own production technology, to provide safe and effective high-quality products, build business reputation and lay a foundation for sustainable development.康友制药控股有限公司注册资金新台币6.8亿元，员工人数约1200人，以六安华源制药有限公司为生产基地，占地面积为300亩。公司专注于原料药及大输液的生产与研发，目前拥有8条大输液生产线，2座原料药生产车间，拥有9种原料药、55种大输液产品生产批文。年生产能力：玻瓶输液25000万瓶/年，塑瓶输液19500万瓶/年，软袋输液（非PVC共挤膜袋）8500万袋/年，尼可刹米原料药300吨/年，乳酸左氧氟沙星原料药160吨/年。公司目前积极跨足动物疫苗生产，联手拥有国际最领先的禽流感技术的哈尔滨维科生物技术开发公司，在印尼投资设立禽用疫苗制造企业，以期扩大成长动能。通过展开海外布局，将实现康友制药产品多元化，从生产人体制药到生产动物疫苗；也将加速康友制药的国际化战略，从中国市场开拓至印尼及东协市场。在关爱生命、勤奋敬业的经营理念下，康友制药控股结合一群顶尖的专业团队，透过自有的生产技术，提供世人安全又有效的高品质产品，打造企业信誉，奠定永续发展的根基。“信誉第一，安全有效”,是我们对客户的承诺，康友制药控股不惜投入巨资，设立先进的品管实验室，引进精密的检测仪器，透过严谨的国际品质规范，生产高品质的药品，满足民众健康优质的用药选择。